The Family Investigation of Nephropathy and Diabetes Study
NCT00301249 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9031
Last updated 2020-04-28
Summary
The Family Investigation of Nephropathy and Diabetes (FIND)Study is a multi-center consortium. The charge of the consortium is to acquire sets of families with well-characterized diabetic nephropathy, establish a secure master FIND database, and perform a genome scan to identify chromosomal regions linked with diabetic nephropathy.
Conditions
- Diabetes
- Diabetic Nephropathy
Sponsors & Collaborators
-
Case Western Reserve University
collaborator OTHER -
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
lead NIH
Principal Investigators
-
Sudha Iyengar, PhD · Case Western Reserve University
-
Barry I Freedman, MD · Wake Forest University
-
Sharon Adler, MD · University of California, Los Angeles
-
Hanna Abboud, MD · University of Texas Health Sciences Center at San Antonio
-
John R Sedor, MD · Case Western Reserve University
-
Rulan Parekh, MD · Johns Hopkins University
-
Philip Zager, MD · University of New Mexico
-
William Knowler, MD, PhD · NIDDK-Phoenix
-
Susanne Nicholas, MD · University of California, Los Angeles
-
Rebekah Rasooly, PhD · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
-
Paul Kimmel, MD · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-10-31
- Primary Completion
- 2006-12-31
- Completion
- 2006-12-31
Countries
- United States
Study Locations
More Related Trials
-
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD
NCT06069076 ·Status: NOT_YET_RECRUITING
-
Prevention of Renal Failure in People Followed for Type 2 Diabetes in General Practice
NCT05749679 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Kidney Biopsy Indications in Type 2 Diabetes Patients
NCT04006028 ·Status: COMPLETED
-
Therapeutic Drug Use for CKD Patients
NCT05818995 ·Status: UNKNOWN
-
Renal Mechanism of Action/Splay vs. TmG
NCT00726505 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
NCT01487109 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
NCT05671991 ·Status: RECRUITING ·Phase: PHASE4
-
The Expression of circANKRD36 as a New Biomarker of Diabetic Nephropathy
NCT05061459 ·Status: UNKNOWN
-
Diabetic Patients With End-Stage Renal Disease
NCT00435786 ·Status: COMPLETED
-
Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy
NCT00253786 ·Status: COMPLETED ·Phase: NA
-
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
NCT07187479 ·Status: RECRUITING ·Phase: NA
-
Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes
NCT01069549 ·Status: COMPLETED
-
The Differential Effects of Diabetes Therapy on Inflammation
NCT02150707 ·Status: COMPLETED
-
A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes
NCT02312050 ·Status: UNKNOWN ·Phase: PHASE2
-
To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy
NCT01163591 ·Status: COMPLETED
-
A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus Patients
NCT05552339 ·Status: COMPLETED
-
T-regulatory Cells in Diabetic Type Two Nephropathy
NCT03591939 ·Status: UNKNOWN
-
To Improve the Ability of Early Screening and Diagnosis in Patients With Diabetic Nephropathy
NCT05047471 ·Status: UNKNOWN
-
CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)
NCT04990427 ·Status: COMPLETED ·Phase: PHASE1
-
Molecular Analysis of Diabetic Kidney Disease Biopsies
NCT04029402 ·Status: RECRUITING
-
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
NCT01101269 ·Status: TERMINATED ·Phase: NA
-
PeRsOnalising Treatment Of Diabetic Nephropathy:
NCT03509454 ·Status: COMPLETED
-
Genetics of Response to Canagliflozin
NCT02891954 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
NCT05378282 ·Status: COMPLETED
-
Delaying the Progression of Diabetic Nephropathy in Pima Indians
NCT00353600 ·Status: COMPLETED